Clinical studies recruiting near Soweto

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With H
Phase 1/Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID · NCT05660980 Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Chris Hani Baragwanath Clinical Trial Site · Hoffmann-La Roche · NCT06793215 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Wits Clinical Research ( Site 2813) · Merck Sharp & Dohme LLC · NCT07216703 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Perinatal HIV Research Unit (PHRU) ( Site 0253) · Merck Sharp & Dohme LLC · NCT07044297 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Wits Clinical Research · Pfizer · NCT06629779 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Wits Clinical Research · Bristol-Myers Squibb · NCT06561386 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Chris Hani Baragwanath Clinical Trial Site · Hoffmann-La Roche · NCT05894239 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · Wits Vaccines & Infectious Diseases Analytics (VIDA) Researc · Bayer · NCT05196035 Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID · NCT06192160 A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Le
Phase 3 · Wits Clinical Research · Hoffmann-La Roche · NCT06790693 A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months
Phase 1 · GSK Investigational Site · GlaxoSmithKline · NCT07406334 A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involv
Phase 4 · Perinatal HIV Research Unit · Gilead Sciences · NCT06337032 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Phase 3 · Wits Vaccines & Infectious Diseases Analytics (VIDA) Researc · Pfizer · NCT07160244 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951 A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor
Phase 3 · Wits Vaccines & Infectious Diseases Analytics (VIDA) Researc · Bayer · NCT05457283 Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
Phase 2 · Perinatal HIV Research Unit (PHRU) · Gilead Sciences · NCT06749054 A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recu
Phase 2/Phase 3 · Local Institution - 0340 · Bristol-Myers Squibb · NCT06926868 A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Phase 3 · Perinatal HIV Research Unit (PHRU) - Chris Hani Baragwanath · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT07209761 A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato
Phase 3 · Wits Vaccines & Infectious Diseases Analytics (VIDA) Researc · University of Witwatersrand, South Africa · NCT06955728 Evaluating the Safety and Immunogenicity of MTBVAC
Phase 2 · HIV Vaccine Trials Network · NCT05947890 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Wits Clinical Research Chris Hani Baragwanath Hospital · Boehringer Ingelheim · NCT07064473 A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Particip
Phase 3 · Wits Clinical Research · Hoffmann-La Roche · NCT06065748 Evaluating Smoking Cessation Interventions for PWH in South Africa
Phase 2/Phase 3 · Perinatal HIV Research Unit (PHRU) · Johns Hopkins University · NCT05413122 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and
Phase 3 · Eli Lilly and Company · NCT07241390 A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obe
Phase 3 · Novo Nordisk A/S · NCT07564414 A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Di
Phase 3 · Wits Clinical Research-Chris Hani Baragwanath Hospital ( Sit · Merck Sharp & Dohme LLC · NCT06430801 RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastati
Phase 2/Phase 3 · Chris Hani Baragwanath Clinical Trial Site · Hoffmann-La Roche · NCT07413939

Look up another city

Look up another condition